Is IgG anti-GT1a antibody associated with pharyngeal-cervical-brachial weakness or oropharyngeal palsy in Guillain-Barre syndrome?

Journal of Neuroimmunology

Volumn 86, Issue 1, 1998, Pages 74-79

  Koga, Michiaki ^a,b   Yuki, Nobuhiro ^a   Ariga, Toshio ^c   Morimatsu, Mitsunori ^b   Hirata, Koichi ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

^b YAMAGUCHI UNIVERSITY   (Japan)

^c EISAI CO LTD   (Japan)

Author keywords

Anti ganglioside antibody; Bulbar palsy; Gillai Barre syndrome; GT1a; Pharyngeal cervical brachial variant

Indexed keywords

GANGLIOSIDE ANTIBODY; GANGLIOSIDE GD 1A; GANGLIOSIDE GQ 1B; GANGLIOSIDE GT 1A; IMMUNOGLOBULIN G ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ANTIBODY TITER; ARTICLE; BRACHIAL PLEXUS; CASE REPORT; CLINICAL FEATURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FACIAL NERVE PARALYSIS; GUILLAIN BARRE SYNDROME; HUMAN; MALE; MUSCLE WEAKNESS; NECK MUSCLE; OPHTHALMOPLEGIA; OROPHARYNX; PRIORITY JOURNAL; PROSPECTIVE STUDY; SUBCLAVIAN STEAL SYNDROME; TENDON REFLEX;

ADULT; AUTOANTIBODIES; BRACHIAL PLEXUS; BULBAR PALSY, PROGRESSIVE; CERVICAL PLEXUS; CROSS REACTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GANGLIOSIDES; HUMANS; IMMUNOGLOBULIN G; MALE; NERVE GROWTH FACTORS; PHARYNGEAL MUSCLES; POLYRADICULONEUROPATHY; PROSPECTIVE STUDIES;

EID: 0032100738     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(98)00016-2     Document Type: Article

References (18)

1. Ando S., Yu R.K. Isolation and characterization of a novel trisialoganglioside, GT1a, from human brain. J. Biol. Chem. 252:1977;6247-6250.
2. Asbury A.K., Cornblath D.R. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann. Neurol. 27(supp.):1990;S21-S24.
3. Carpo M., Nobile-Orazio E., Meucci N., Gamba M., Barbieri S., Allaria S., Scarlato G. Anti-GD1a ganglioside antibodies in peripheral motor syndromes. Ann. Neurol. 39:1996;539-543.
4. Chiba A., Kusunoki S., Obata H., Machinami R., Kanazawa I. Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barré Syndrome: clinical and immunohistochemical studies. Neurology. 43:1993;1911-1917.
5. Hirabayashi Y., Nakao T., Matsumoto M. Improved method for large-scale purification of brain gangliosides by Q-Sepharose column chromatography: immunochemical detection of C-series polysialogangliosides in adult bovine brains. J. Chromatogr. 445:1988;377-384.
6. Hughes, R.A.C., 1990. Guillain-Barré Syndrome. Springer-Verlag, London, pp. 121-140.
7. Kamata Y., Kozaki S., Sakaguchi G., Iwamori M., Nagai Y. Evidence for direct binding of Clostridium botulinum type E derivative toxin and its fragments to gangliosides and free fatty acids. Biochem. Biophys. Res. Commun. 140:1986;1015-1019.
8. Kitamura M., Iwamori M., Nagai Y. Interaction between Clostridium botulinum neurotoxin and gangliosides. Biochim. Biophys. Acta. 628:1980;328-335.
9. Lugaresi A., Ragno M., Torrieri F., Di Guglielmo G., Fermani P., Uncini A. Acute motor axonal neuropathy with high titer IgG and IgA anti-GD1a antibodies following Campylobacter enteritis. J. Neurol. Sci. 147:1997;193-200.
10. Mizoguchi K., Hase A., Obi T., Matsuoka H., Takatsu M., Nishimura Y., Irie F., Seyama Y., Hirabayashi Y. Two species of antiganglioside antibodies in a patient with a pharyngeal-cervical-brachial variant of Guillain-Barré Syndrome. J. Neurol. Neurosurg. Psychiatry. 57:1994;1121-1123.
11. O'Leary C.P., Veitch J., Durward W.F., Thomas A.M., Rees J.H., Willison H.J. Acute oropharyngeal palsy is associated with antibodies to GQ1b and GT1a ganglioside. J. Neurol. Neurosurg. Psychiatry. 61:1996;649-651.
12. Ropper A.H. Unusual clinical variants and signs in Guillain-Barré Syndrome. Arch. Neurol. 43:1986;1150-1152.
13. Ropper, A.H., Wijdicks, E.F.M., Truax, B.T., 1991. Guillain-Barré Syndrome. F.A. Davis, Philadelphia, pp. 18-121 and 73-105.
14. Ropper A.H. Further regional variants of acute immune polyneuropathy. Arch. Neurol. 51:1994;671-675.
15. Visser, L.H., van der Meché, F.G.A., van Doorn, P.A., Meulstee, J., Jacobs, B.C., Oomes, P.G., Kleyweg, R.P. and the Dutch Guillain-Barré study group, 1995. Guillain-Barré Syndrome without sensory loss (acute motor neuropathy): a subgroup with specific clinical, electrodiagnostic and laboratory features. Brain 118, 841-847.
16. Yuki N., Yoshino H., Sato S., Shinozawa K., Miyatake T. Severe acute axonal form of Guillain-Barré Syndrome associated with IgG anti-GD1a antibodies. Muscle Nerve. 15:1992;899-903.
17. Yuki N. Acute paresis of extraocular muscles associated with IgG anti-GQ1b antibody. Ann. Neurol. 39:1996;668-672.
18. Yuki N., Taki T., Handa S. Antibody to GalNAc-GD1a and GalNAc-GM1b in Guillain-Barré Syndrome subsequent to Campylobacter jejuni enteritis. J. Neuroimmunol. 71:1996;155-161.